The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Glaukos Corporation(NYSE:GKOS) 
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outf...
Website: http://www.glaukos.com
Founded: 1998
Full Time Employees: 600
Sector: Healthcare
Industry: Medical Instruments & Supplies
Glaukos Days Payable Outstanding ttm (DPO)
Glaukos Days Receivable Outstanding ttm (DSO)
Glaukos Days Inventory Outstanding ttm (DIO)
Glaukos Op Cashflow Per Share ttm
Glaukos Free Cashflow Per Share ttm
Glaukos Cash Per Share ttm
Glaukos P/S ratio ttm
Glaukos (GAAP) P/E ratio ttm
Glaukos P/B ratio ttm
No extra charts and metrics for this ticker.